No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Express News | Cantor Fitzgerald Reiterates Overweight on Cidara Therapeutics
Cidara Therapeutics(CDTX.US) Officer Buys US$105.68K in Common Stock
Cidara Therapeutics to Present Preclinical Data on CD388 at ASM Microbe 2024 Conference
Cidara Therapeutics Inc. Hits Snag: Delayed 10-K Filing Complicates Capital Raising Efforts
Express News | Needham Reiterates Buy on Cidara Therapeutics, Maintains $25 Price Target
Cidara Therapeutics Analyst Ratings